Dimethandrolone dodecylcarbonate
Dimethandrolone dodecylcarbonate (developmental code name CDB-4730), or dimethandrolone dodecanoylcarbonate, also known as 7α,11β-dimethyl-19-nortestosterone 17β-dodecylcarbonate, is a synthetic and orally active anabolic–androgenic steroid (AAS) and a derivative of nandrolone (19-nortestosterone) which was developed by the Contraceptive Development Branch (CDB) of the National Institute of Child Health and Human Development (NICHD) and has not been marketed at this time.[1] It is an androgen ester – specifically, the C17β dodecylcarbonate ester of dimethandrolone (7α,11β-dimethyl-19-nortestosterone) – and acts as a prodrug of dimethandrolone in the body.[1]
Clinical data | |
---|---|
Other names | CDB-4730; Dimethandrolone dodecanoylcarbonate; Dimethandrolone 17β-dodecylcarbonate; 7α,11β-Dimethyl-19-nortestosterone 17β-dodecylcarbonate |
Routes of administration | By mouth, intramuscular injection[1] |
Drug class | Androgen; Anabolic steroid; Progestogen |
Identifiers | |
IUPAC name
| |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C33H54O4 |
Molar mass | 514.7795 g/mol g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
See also
References
- Blye, Richard P., and Hyun K. Kim. "Nandrolone 17β-carbonates." U.S. Patent No. 7,820,642. 26 Oct. 2010.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.